Schroeder Theodore R Insider Trades

Insider Trading History

Track insider trading activity for Schroeder Theodore R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $445k 45,122 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 24,122 shares
$11.40
$9.86
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $0 0 shares
Last Trade
Jan 07, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.1M 41,100 shares
$221.38
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $2.46M 11,100 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$237k 11,100 shares
$21.31
$221.38
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $345k 35,000 shares
Last Trade
Apr 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 35,000 shares
$4.23
$9.86
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $4.54M 20,500 shares
Last Trade
Dec 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$468k 20,500 shares
$22.81
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $470k 2,125 shares
Last Trade
Jul 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 2,125 shares
$12.64
$221.38
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $9.41M 42,500 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$995k 42,500 shares
$23.40
$221.38
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Director
Holding Value $17k 11,989 shares
Last Trade
Jan 29, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$647 431 shares
$1.50
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.6k 12,420 shares
Last Trade
Jan 06, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.3 11 shares
$1.30
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.7k 12,431 shares
Last Trade
Dec 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.45 5 shares
$1.89
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.7k 12,436 shares
Last Trade
Dec 06, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.2 9 shares
$2.02
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.7k 12,445 shares
Last Trade
Nov 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.3 5 shares
$2.25
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.7k 12,450 shares
Last Trade
Nov 06, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.4 10 shares
$2.24
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.7k 12,460 shares
Last Trade
Oct 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.7 5 shares
$2.54
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.7k 12,465 shares
Last Trade
Oct 06, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$24.5 9 shares
$2.72
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $17.7k 12,474 shares
Last Trade
Sep 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.4 5 shares
$2.08
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $443k 311,977 shares
Last Trade
Sep 06, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$881 225 shares
$3.92
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $443k 312,202 shares
Last Trade
Aug 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$440 107 shares
$4.12
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $341k 239,800 shares
Last Trade
Aug 11, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.16M 239,800 shares
$4.84
$1.42
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc NBRV
Chief Executive Officer
Holding Value $443k 312,309 shares
Last Trade
Aug 06, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.04k 225 shares
$4.62
$1.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up